1. Introduction {#s1}
===============

Acute aortic dissection (AAD) is a rare but potentially disastrous disease. The reported mortality rate of AAD is 1% to 2% per hour after the first 24 to 48 h of symptom onset.[@b1] Type A AAD develops rapidly and is often accompanied by life-threatening complications, such as aortic rupture, cardiac tamponade, coronary obstruction, or visceral ischemia, which requires urgent surgical management.[@b1]--[@b3] Despite improved surgical techniques in recent years, in-hospital mortality in patients with type A AAD remains high, ranging from 10% to 35%.[@b4]--[@b10]

Acute kidney injury (AKI) is common after aortic surgery for AAD and increases in-hospital and long-term mortality.[@b11]--[@b14] Recent study showed preoperative renal function could effectively predict the need for renal replacement therapy after surgery for type A AAD.[@b15] However, there is a paucity of data regarding early preoperative AKI and its clinical and prognostic relevance in patients with type A AAD. In the present study, we aimed to investigate the incidence and predictors of early preoperative AKI and the impact of AKI on in-hospital outcomes in patients with type A AAD.

2. Methods {#s2}
==========

2.1. Study population {#s2a}
---------------------

From May 2009 to June 2014, 261 consecutive patients who underwent open surgery for type A AAD were reviewed at Beijing Anzhen Hospital, Capital Medical University. Since this study focused on early AKI, patients admitted to our hospital more than 48 h from symptom onset (*n* = 73) were excluded. Patients with recurrent AAD (*n* = 1), chronic renal failure on renal replacement therapy (*n* = 1), and those with data incompleteness were also excluded from our study (*n* = 8). Finally, a total of 178 patients were included in this study. Clinical variables were collected, including patient demographics and history, physical findings, laboratory tests, imaging findings, and patient outcomes including in-hospital complications and mortality. This study complied with the Declaration of Helsinki, and was approved by the institutional ethical committee of Beijing Anzhen Hospital, Capital Medical University. All patients provided written informed consent.

2.2. Study protocol {#s2b}
-------------------

Aortic dissection was diagnosed by contrast-enhanced CT and defined as type A or type B according to Stanford classification.[@b16] Both the true and false lumens of the dissected aorta were defined according to CT imaging. The false lumen was further classified into the thrombosed false lumen (partial thrombosis or complete thrombosis) and the patent false lumen. The extent of renal artery involvement was also acquired. The imaging findings were analyzed by two independent experienced radiologists.

Blood samples for measurements of the serum creatinine (SCr) level were obtained on admission and every day before surgery to achieve at least two time points for blood sampling. In addition, the serum C-reactive protein (CRP), hemoglobin, and glucose levels were obtained on admission.

According to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines,[@b17] AKI was defined as an increase in SCr ≥ 0.3 mg/dL (≥ 26.5 µmol/L) within 48 h or an increase in SCr ≥ 1.5 times baseline, which is known or presumed to have occurred within the prior seven days. Due to a lack of urine output data, AKI was merely defined by changes in SCr. Preoperative AKI was defined as occurrence of AKI before aortic surgery. Preoperative AKI was also staged for severity according to the following criteria: stage 1, an increase in SCr ≥ 0.3 mg/dL (≥ 26.5 µmol/L) or 1.5 to 1.9 times baseline; stage 2, 2.0 to 2.9 times baseline; stage 3, an increase in SCr ≥ 4.0 mg/dL, or ≥ 3.0 times baseline, or initiation of renal replacement therapy.

Patients were divided into no AKI (*n* = 137) and AKI (*n* = 41) groups according to the changes in SCr. The AKI group was further classified as stage 1 (*n* = 19), stage 2 (*n* = 17), and stage 3 (*n* = 5). We evaluated the relations between the incidence and severity of early preoperative AKI and clinical outcomes including in-hospital complications such as renal infarction, acute lung injury, acute visceral ischemia, acute heart failure, stroke, aortic rupture, re-exploration for bleeding, and multiple systemic organ failure. The in-hospital mortality, duration on mechanical ventilation, and the lengths of intensive care unit (ICU) stay and hospital stay were also compared between the AKI and no AKI groups. Renal infarction was defined by the presence of a low-density area without enhanced contrast on CT scan, caused by thrombotic occlusion of either the main renal artery or the arterial branches. Acute lung injury was confirmed by the ratio of the arterial partial pressure of oxygen to the fraction of inspired oxygen ≤ 200 mmHg. Stroke included cerebral hemorrhage and ischemic cerebral infarction.

2.3. Statistical analysis {#s2c}
-------------------------

Categorical variables were presented as frequencies and percentages, while the continuous variables were presented as means ± SD or median (interquartile range). Chi-square test, Fisher\'s exact test, or Cochran-Armitage trend test were used to compare categorical variables, and unpaired Student *t* test or Wilcoxon rank sum test to compare continuous variables. To determine the independent predictors of AKI, stepwise multivariate logistic regression analyses were performed including variables with *P* \< 0.3 by univariate analyses. A *P* value \< 0.05 was considered statistically significant. Data analysis was performed using SAS 9.1 software (SAS Institute, Inc, Cary, NC, USA).

3. Results {#s3}
==========

3.1. Demographic and clinical features {#s3a}
--------------------------------------

Among the 178 patients with type A AAD, 41 patients (23.0%) exhibited AKI, including 19 patients (10.7%) in stage 1, 17 patients (9.6%) in stage 2, and 5 patients (2.8%) in stage 3. Patient characteristics are presented in [Table 1](#jgc-13-08-679-t01){ref-type="table"} and [2](#jgc-13-08-679-t02){ref-type="table"}. Compared with patients without AKI, patients with AKI were predominantly male (*P* = 0.004). There were no significant differences in terms of cardiovascular risk factors between the two groups ([Table 1](#jgc-13-08-679-t01){ref-type="table"}). The time from symptom onset to admission was similar between AKI and no AKI groups. Patients with AKI had lower diastolic blood pressure (BP) on admission (*P* = 0.033). Patients with AKI presented significantly higher SCr on admission compared to no AKI group (*P* \< 0.001). According to the CT findings, the status of the false lumen showed no significant differences between the AKI and no AKI groups. Renal artery involvement (mainly bilateral involvement) occurred more frequently in patients with AKI (*P* = 0.004). These mainly consisted of renal arterial stenosis or thrombosis. The aortic diameter and aortic regurgitation indicated no obvious differences between the two groups ([Table 2](#jgc-13-08-679-t02){ref-type="table"}).

###### Demographics and patient history of patients with or without acute kidney injury.

  Variables                   No AKI (*n* = 137)   AKI (*n* = 41)   *P* value\*       AKI                    
  -------------------------- -------------------- ---------------- ------------- ------------- ------------- -------------
  Age, yrs                        47.8 ± 9.4        48.1 ± 12.0        0.679      49.7 ± 14.8   47.5 ± 9.6    44.4 ± 7.8
  Male                           102 (74.5%)         39 (95.1%)        0.004      18 (94.7%)     17 (100%)      4 (80%)
  Height, cm                     171.1 ± 6.7        173.1 ± 5.5        0.097      174.5 ± 5.6   171.9 ± 2.0   170.3 ± 9.5
  Weight, kg                     76.9 ± 12.3         80.1 ± 9.2        0.156      80.9 ± 8.7    81.2 ± 10.3   73.8 ± 7.5
  Body mass index, kg/m^2^        26.2 ± 3.5         26.7 ± 2.5        0.466      26.5 ± 2.2    27.5 ± 3.3    25.4 ± 0.8
  Hypertension                    90 (65.7%)         31 (75.6%)        0.233      15 (79.0%)    13 (76.5%)      3 (60%)
  Diabetes mellitus                4 (2.9%)              0             0.269           0             0             0
  Cerebrovascular disease          2 (1.5%)           2 (4.9%)         0.195           0         2 (11.8%)         0
  Smoking                         65 (47.5%)         24 (58.5%)        0.213      11 (57.9%)    11 (64.7%)      2 (40%)

Data are presented as mean ± SD, or *n* (%). \*Comparing between no AKI and AKI groups. AKI: acute kidney injury.

###### Clinical, laboratory, and imaging findings of patients with or without acute kidney injury.

  Variables                          No AKI (*n* = 137)    AKI (*n* = 41)     \**P* value          AKI                             
  --------------------------------- -------------------- ------------------- ------------- ------------------- ------------------- -------------------
  Time from onset to admission, h       28.0 ± 15.4          27.3 ± 19.8         0.325         27.6 ± 22.7         28.0 ± 19.4         23.6 ± 9.2
  Systolic BP on admission, mmHg        132.1 ± 19.7        125.2 ± 23.9         0.097        120.3 ± 18.6       129.41 ± 27.47       129.4 ± 30.71
  Diastolic BP on admission, mmHg       71.7 ± 12.8          66.3 ± 14.9         0.033         67.0 ± 15.9         64.5 ± 13.4         73.6 ± 17.5
  LVEF, %                                64.1 ± 7.4          62.6 ± 7.5          0.208         61.5 ± 5.5          61.9 ± 7.5          67.8 ± 12.0
  Laboratory data on admission                                                                                                     
   Hemoglobin, g/dL                      13.1 ± 2.1          13.5 ± 1.6          0.371         13.5 ± 1.6          13.6 ± 1.4          12.9 ± 2.2
   Glucose, mg/dL                       142.3 ± 50.1        147.2 ± 37.1         0.101        148.8 ± 36.9        139.3 ± 39.1        168.8 ± 26.1
   SCr, mg/dL                        0.75 (0.69--0.83)    1.18 (1.11--1.38)    \< 0.001     1.14 (1.07--1.24)   1.37 (1.15--1.41)   1.38 (1.27--1.47)
   CRP, mg/dL                           25.5 ± 13.4          28.6 ± 14.6         0.268         23.2 ± 13.9         30.9 ± 16.0         34.1 ± 13.6
  CT findings                                                                                                                      
  Status of the false lumen                                                      0.324                                             
   Patent                                93 (67.9%)          26 (63.4%)                         8 (42.1%)          14 (82.4%)            4 (80%)
   Partial thrombosis                    41 (29.9%)          12 (29.3%)                         9 (47.4%)           2 (11.8%)            1 (20%)
   Complete thrombosis                    3 (2.2%)            3 (7.3%)                          2 (10.5%)           1 (5.9%)                0
  Renal artery involvement                                                       0.004                                             
   No involvement                        62 (45.3%)          13 (31.7%)                         8 (42.1%)           4 (23.5%)            1 (20%)
   Unilateral involvement                68 (49.6%)          18 (43.9%)                         7 (36.8%)           9 (52.9%)            2 (40%)
   Bilateral involvement                  7 (5.1%)           10 (24.4%)                         4 (21.1%)           4 (23.5%)            2 (40%)
  Aortic diameter, mm                    48.0 ± 8.7          49.3 ± 10.2         0.443         50.1 ± 11.5         48.45 ± 9.5         49.0 ± 8.8
  Aortic regurgitation                   67 (48.9%)          19 (46.3%)          0.773         11 (57.9%)           6 (35.3%)            2 (40%)

Data are presented as mean ± SD, median (interquartile range), or *n* (%). \*Comparing between no AKI and AKI groups. AKI: acute kidney injury; BP: blood pressure; CRP: C-reactive protein; CT: computed tomography; LVEF: left ventricular ejection fraction; SCr: serum creatinine.

3.2. In-hospital outcomes {#s3b}
-------------------------

Patients with AKI before surgery had a significantly higher incidence of in-hospital complications compared with those without AKI (41.5% *vs.* 9.5%, *P* \< 0.001; [Table 3](#jgc-13-08-679-t03){ref-type="table"}). There was a significant trend toward increased frequency of overall complications along with the severity of AKI (no AKI, 9.5%; stage 1, 31.6%; stage 2, 47.1%; stage 3, 60.0%; *P*~trend~ \< 0.001; [Table 3](#jgc-13-08-679-t03){ref-type="table"} and [Figure 1](#jgc-13-08-679-g001){ref-type="fig"}). In particular, renal infarction occurred more frequently in the AKI group, and these complications were more pronounced in patients with relatively severe AKI. Other complications, such as acute lung injury, acute visceral ischemia, acute heart failure, stroke, aortic rupture, re-exploration for bleeding, and multiple systemic organ failure, showed no significant differences between the two groups, although they were more common in the AKI group. The in-hospital mortality was 14.6% and 5.1% in patients with AKI and without AKI, respectively, although no significant difference was observed (*P* = 0.079). Duration of ICU stay was longer in patients with AKI than in those without AKI ([Table 3](#jgc-13-08-679-t03){ref-type="table"}).

###### Impact of preoperative acute kidney injury on in-hospital outcomes.

  Variables                             No AKI (*n* = 137)   AKI (*n* = 41)   \**P*-value        AKI                        
  ------------------------------------ -------------------- ---------------- ------------- --------------- ---------------- --------------------
  In-hospital complications                 13 (9.5%)          17 (41.5%)      \< 0.001       6 (31.6%)       8 (47.1%)           3 (60%)
   Renal infarction                             0               3 (7.3%)         0.012        1 (5.3%)         1 (5.9%)           1 (20%)
   Acute lung injury                         2 (1.5%)           2 (4.9%)         0.228            0            1 (5.9%)           1 (20%)
   Acute visceral ischemia                      0               2 (4.9%)         0.052        1 (5.3%)         1 (5.9%)              0
   Acute heart failure                          0               1 (2.4%)         0.230            0            1 (5.9%)              0
   Stroke                                    3 (2.2%)           3 (7.3%)         0.136        1 (5.3%)        2 (11.8%)              0
   Aortic rupture                            3 (2.2%)           2 (4.9%)         0.325        1 (5.3%)         1 (5.9%)              0
   Re-exploration for bleeding               1 (0.7%)           1 (2.4%)         0.409            0               0               1 (20%)
   Multiple systemic organ failure           1 (0.7%)           2 (4.9%)         0.133        1 (5.3%)            0               1 (20%)
   Mortality                                 7 (5.1%)          6 (14.6%)         0.079        3 (15.8%)       3 (17.7%)              0
  Mechanical ventilation duration, h     19.5 (15--63.5)     36.5 (20--65)       0.266      26.5 (20--36)   71.5 (37--279)     114.5 (40-189)
  Duration of ICU stay, h                  39 (22--86)        69 (34--120)       0.008       65 (32--96)     62 (29--120)    134.5 (109--164.5)
  Duration of hospital stay, days          15 (10--20)         12 (4--20)        0.164       11 (4--22)       11 (2--17)        20 (16--25)

Data are presented as median (interquartile range), or *n* (%). \*Comparing between no AKI and AKI groups. AKI: acute kidney injury; ICU: intensive care unit.

![The incidence of in-hospital complications in patients without AKI, developing AKI stage 1, AKI stage 2, and AKI stage 3.\
AKI: acute kidney injury.](jgc-13-08-679-g001){#jgc-13-08-679-g001}

3.3. Predictors of AKI {#s3c}
----------------------

On the final logistic regression, after adjusting for baseline variables, we identified male gender (OR = 5.398; 95% CI: 1.497--19.468; *P* = 0.01), diastolic BP on admission (OR = 0.961; 95% CI: 0.943--0.980; *P* \< 0.001), and bilateral renal artery involvement (OR = 5.392; 95% CI: 1.390-- 20.914; *P* = 0.015) were independent predictors of preoperative AKI in patients with type A AAD ([Table 4](#jgc-13-08-679-t04){ref-type="table"}).

4. Discussion {#s4}
=============

In the present study, we demonstrated that early preoperative AKI was associated with increased in-hospital complications in patients with type A AAD. The incidence of in-hospital complications increased with increasing AKI stage. Moreover, we found that male gender, diastolic BP on admission, and bilateral renal artery involvement were independent predictors of preoperative AKI.

###### Multivariate logistic regression analyses for predictors of acute kidney injury.

  Variables                        OR (95% CI)        *P* Value
  -------------------------- ----------------------- -----------
  Gender                                             
   Female                           Reference        
   Male                       5.398 (1.497--19.468)     0.01
  Diastolic blood pressure    0.961 (0.943--0.980)    \< 0.001
  Renal artery involvement                           
   Non                              Reference        
   Unilateral                 0.902 (0.346--2.352)      0.833
   Bilateral                  5.392 (1.390--20.914)     0.015

Emergency open surgery is the mainstay of treatment for type A AAD. However, the operative mortality remains substantial (between 10% and 35%) in the past two decades.[@b4]--[@b10] In the contemporary International Registry of acute Aortic Dissection (IRAD) study, the in-hospital mortality for type A AAD receiving timely and successful surgery was 26.9%, although it was less than the 56.2% mortality with medical therapy.[@b5] AKI is common after thoracic aortic surgery and is associated with increased in-hospital complications and short- and long-term mortality.[@b11]--[@b14] It can be speculated that type A AAD evolves rapidly and AKI might have occurred early before surgery. However, there are few data concerning the incidence and prognostic value of preoperative AKI in patients with type A AAD. In the present study, according to the new KDIGO criteria, the incidence of AKI before surgery was 23.0%, which was relatively low compared with that of AKI (RIFLE criteria) after surgery (48%--55%) in other studies.[@b11],[@b12],[@b18],[@b19] Even so, patients with preoperative AKI had a 4.5-fold higher rate of in-hospital complications than those without AKI (41.5% *vs.* 9.5%), and the risk of complications increased with each AKI stage, which indicates that preoperative AKI may serve as a good outcome predictor as postoperative AKI. In consistent with previous studies,[@b11],[@b12],[@b20] patients with AKI experienced more renal infarction, which was an indicator of poor outcomes. More recently, Imasaka, *et al*.,[@b15] confirmed that preoperative estimated glomerular filtration rate was useful in predicting the need for postoperative renal replacement therapy for type A AAD, whereas it was not an effective predictor for in-hospital mortality. In our study, the in-hospital mortality tended to be higher in patients with AKI compared to no AKI, but with no significant difference. These results may be partly explained by the fact that various complications or surgery-related factors affect in-hospital outcomes.

After adjusting for baseline variables, multivariate analyses showed that male gender, diastolic BP and bilateral renal artery involvement were independent predictors of AKI. Of the AKI patients in our study, males far outnumbered females, which was similar to those of previous studies.[@b11],[@b12],[@b14],[@b20] Reduction of renal blood flow, whether generalized or localized, plays a pivotal role in the pathophysiology of AKI.[@b21] Lower diastolic BP on admission was associated with reduced visceral perfusion, causing generalized ischemia to the kidney leading to AKI. Extension of the dissection may involve the renal artery causing thrombosis or stenosis, which may directly impair renal perfusion, thus resulting in AKI.[@b22] Obviously, bilateral renal artery involvement was more harmful. However, in the setting of acute dissection, strategies to improve renal perfusion (e.g., increasing the baseline BP or renal replacement therapy) are not feasible and may delay the timing of surgery. In this case, prompt surgery is needed to inhibit extension of the dissection and improve renal perfusion. Previous report showed that a long cardiopulmonary bypass duration (\> 180 min) was a strong risk factor for postoperative AKI.[@b12] Therefore, shorter cardiopulmonary bypass time should be considered to prevent further renal impairment and improve in-hospital outcomes.

There are several potential limitations. First, our study was a single-center retrospective study, which might include a nonhomogeneous population. Second, although each group\'s sample size is relatively small, statistical significances were observed between AKI and no-AKI groups regarding in-hospital complications. However, the statistical power may not be sufficient for comparison among different AKI stages due to the relatively small number of patients. Third, patients with AKI were classified only by SCr levels, which may not be the most sensitive marker. Urine output changes were not available for this retrospective study. Several markers of AKI (i.e., Cystatin C, N-acetyl-beta-D-glucosaminidase, neutrophil gelatinase-associated lipocalin, etc) should be considered and allow a more precise diagnosis and earlier management of AKI in the future study. Fourth, patients with deaths before admission were not included in this study, and some patients abandoned treatment and were automatically discharged from the hospital due to various reasons. Thus, the in-hospital mortality may be underestimated.

In conclusion, early AKI before open surgery was common in patients with type A AAD. Preoperative AKI was associated with increased in-hospital complications. Furthermore, male gender, diastolic BP on admission and bilateral renal artery involvement were independent predictors for preoperative AKI.
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